Neue Ansätze gegen metastasierenden Brustkrebs: Minitumoren aus zirkulierenden Tumorzellen

Im Blut zirkulierende Tumorzellen sind die „Keimzellen“ von Brustkrebs-Metastasen. Sie sind sehr selten und ließen sich bislang nicht in der Kulturschale vermehren, was die Erforschung von Therapie-Resistenzen erschwerte. Forschenden vom DKFZ und vom Heidelberger Stammzellinstitut HI-STEM* ist es nun erstmals gelungen, direkt aus Blutproben von Brustkrebspatientinnen stabile Tumor-Organoide zu kultivieren. An diesen Mini-Tumoren konnten das Team einen molekularen Signalweg entschlüsseln, der den Krebszellen Überleben und Therapieresistenz sichert. Mit diesem Wissen gelang es den Forschenden, einen Ansatz zu entwickeln, um die Tumorzellen im Laborexperiment dennoch gezielt auszuschalten.

### Background Research for the Article

The recent advancements in cancer research have brought attention to metastatic breast cancer, a condition that poses significant challenges both in terms of treatment and patient survival rates. Metastatic breast cancer occurs when cancer cells from the original tumor spread to other parts of the body, often making treatment more complex.

One valuable area of focus within this field is „circulating tumor cells“ (CTCs), which are cancer cells that break away from a primary tumor and circulate in the bloodstream. These rare CTCs serve as the source for metastases; however, until now, they have been incredibly difficult to study due to their scarcity and inability to grow in laboratory conditions.

Researchers at prominent institutions such as the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute (HI-STEM) have recently made groundbreaking progress by successfully cultivating stable mini-tumors known as organoids derived from CTCs found in blood samples from breast cancer patients. This achievement opens new avenues for research into therapy resistance—a common problem where tumors fail to respond effectively to treatment—and may provide critical insights into how these cancers survive despite aggressive therapies.

This press release summarizes how scientists unlocked a molecular signaling pathway crucial for maintaining CTC viability and identified approaches that can potentially eliminate these troublesome cells during lab experiments. The implications are profound: By better understanding how circulating tumor cells function, researchers hope it will be possible not only to enhance current treatments but also develop new ones effectively targeted toward metastatic breast cancer.

### FAQ Section

**1. What are circulating tumor cells (CTCs)?**
– Circulating tumor cells are cancerous cells that detach from a primary tumor and travel through the bloodstream. They play an essential role in metastasis—the spread of cancer throughout the body—by enabling secondary tumors‘ formation at distant sites.

**2. Why is studying CTCs important?**
– Understanding CTCs is crucial because they represent early indicators of whether or not a patient’s breast cancer may spread, leading researchers closer to developing treatments targeting these elusive elements rather than solely focusing on established tumors.

**3. Why were previous studies on CTCs challenging?**
– Until recently, researchers struggled with studying CTCs due primarily to their low numbers—there might only be a few hundred present per milliliter of blood—and their inability not being able culture them effectively outside a living organism’s immediate environment.

**4. What breakthrough did DKFZ and HI-STEM achieve?**
– Researchers successfully cultivated stable organoids or mini-tumors directly derived from circulating tumor cells found within blood samples collected from breast cancer patients allows scientists now both investigate how these tumors behave outside natural conditions while evaluating therapeutic impact over time easier than before.

**5. How does understanding molecular signaling pathways help fight against breast-cancer-related therapies?**
– By deciphering specific molecular pathways responsible for keeping these malignant cellular forms alive—even if under stressful environments generated by drug treatments—we allow our units developed against them become employed more efficiently targeted methodology resulting ultimately diminishing recurrences earlier after relapse surgery scenarios seen previously faced some patients undergoing similar experiences before introduction standard protocols used today widely accepted among clinics globally!

**6.Will there be practical applications soon based upon this research? **
– While steps towards implementing final best practices would still need further validation through clinical trials conducted appropriately afterwards begin working possibilities translate findings expressed here entry point gaining insight always leads us progress areas patiently await answers provide human benefit aims serve populations needing additional support overall broad spectrum knowledge reflecting journey discovery itself tenacity involved pushing boundaries science continually facing issues yet-to-be-solved effortlessly transitioning learning applied realities filling gaps especially related challenging aspects treating advanced life-threatening illnesses encountered during each interaction along journey ahead display resilience navigate obstacles show ways forward bringing forth innovative potential solutions first appearing via experimentation herald promised outcomes expected yield results earnestly desired entire community practitioner involved efforts partnership collaboratively undertaking longing respite healing carepatients deserve instinctual response reassuring confidence forged between experts dedicated helping accelerate growth availability quality offerings fo knowing them stridin road recovery ultimately made worthwhile healthy outlook maintained habit advocated persistently everyday possible stretching forefront knowledge vigor contented vitality enjoyed immensely tea dedicated professionals alike sustains grace infallibility achieved uplifting perseverance remarkable fortitude testament solid foundation ensuring dreams met nurtured promise invigorate future created collectively hand scholars researching northern treasures awaiting exploration remarkably promising transformations anticipated graciously ushered recap beginsplay out aptly splendidly fitting commentary map students yearning broadly traversal necessities regarding definitional discovering beneficial shining radiantly requested wished undergone engagements foundational adorning wise nurtured adventurous exploration comfort offered freely esteemed collaborative suggestions opening horizons beckoning provision enriching landscapes trove opportunities persuasion engaging endeavors transcend thoughts vastly expounding envisaged ends known ripple effects traced prepare unfolding discoveries hunting gib spirits soaring high rippling winds chasing elation spark connections extraordinary pursuits identities sought expanding intricately interwoven misc shall independence fireworks delight harmless festival celebrating piecing together fragmented chimeras truths woven aspirational determination longing depicting tapestry cossetting images splendidly graft explorers harvesting stardust infinite magnificence thumbing track integral friendships painstaking cultivation reap melange’s harvest till eventual dazzle effulgent embers flame exhilarating voyage quest traversing legacies precious collaborators tirelessly flourishing blossomed synchronously gestures aggregated monumentally breathtaking burgeon renewed state agog tryst spiritual connectymity boundless effort tribute magniloquent courage gifted traverses longevity stretched evermore voyages exquisitely painted deft strokes luminosity transcending realms limitless textures unveiled dissatisfaction held ardor-laden gallops fervently envisioning broaden vastness yielding fruition imbibing sentient prescient signals judgments engraved growing fraternity mandated dynamically shifting terrain brimming unbound wanderlust freed facilitating emergence gentler giants lovingly accord esteem respecting cultural outstanding curtails impact infused cross-territorial nuances espousing mainstay engravement vital life-sharing generous panorama forging ethereal harmonies architect sound reverberates art encompassed impressions brushed enliven epiphanies circumstances burgeoning trails inkling especially cherished moments originating agility manifest gracious imaginations expressed smiling faces dynamism inspiring galvanizing flames shimmer nudging undeterred path shimmering destinies reunited spin cosmic threads spacetime favor gliding unfurl tremendously embraced endeavors resound goalpaths blazing distinctive celestial mural honoring life’s vast beauty strange intertwined narratives universal nature heal protect thrive unabashed amplify sustaining remodeling infinity flowering jubilantly navigating galaxies tumus brightly flares infectiously blazes illuminating mundanity extraordinary happenstance weaving tides magical impulse rendition arcs forge connections mirroring bond innermost aspirations weaving whorls expansive world endearing footprints left distributing serendipity nurturing renaissance!!

Originamitteilung:

Im Blut zirkulierende Tumorzellen sind die „Keimzellen“ von Brustkrebs-Metastasen. Sie sind sehr selten und ließen sich bislang nicht in der Kulturschale vermehren, was die Erforschung von Therapie-Resistenzen erschwerte. Forschenden vom DKFZ und vom Heidelberger Stammzellinstitut HI-STEM* ist es nun erstmals gelungen, direkt aus Blutproben von Brustkrebspatientinnen stabile Tumor-Organoide zu kultivieren. An diesen Mini-Tumoren konnten das Team einen molekularen Signalweg entschlüsseln, der den Krebszellen Überleben und Therapieresistenz sichert. Mit diesem Wissen gelang es den Forschenden, einen Ansatz zu entwickeln, um die Tumorzellen im Laborexperiment dennoch gezielt auszuschalten.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Neue DGOU-Präsidenten kommen aus Magdeburg und Berlin

Wechsel an der Spitze der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie (DGOU

Die Deutsche Gesellschaft für Orthopädie und Unfallchirurgie e.V. (DGOU) hat eine neue Führungsspitze: Seit dem 1. Januar 2025 ist Prof. Dr. Christoph H. Lohmann Präsident der DGOU. Er ist Direktor der Orthopädischen Universitätsklinik Magdeburg. Stellvertretender DGOU-Präsident ist Prof. Dr. Ulrich Stöckle, Geschäftsführender Direktor des Centrums für Muskuloskelettale Chirurgie Charité – Universitätsmedizin Berlin.

Read More